Search
Prelude Therapeutics Inc
PRLDAdd to Watchlist
3.450USD
-0.070-1.99%
Close 11-13 16:00（ET）
275.31MMarket Cap
LossP/E TTM
Today
-1.99%
5 Days
-4.17%
1 Month
+6.81%
6 Months
-22.82%
Year to Date
+18.97%
1 Year
+126.97%
Key Figures
3.530Open
3.730High
32.77KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
3.520Prev. Close
3.290Low
112.44KTurnover
LossP/E Static
2.06P/B
0.00%Div Yield TTM
-59.64%ROA
6.83052wk High
0.13Volume Ratio
-127.17MNet Profit
79.80MShares
-0.9965EPS TTM
1.02Beta
-95.25%ROE
1.29552wk Low
12.50%Amplitude
100.00%Gross Margin
275.31MMarket Cap
2.99Reward/Risk
6.88%Risk Rate
More news coming soon, stay tuned...
Prelude Therapeutics Inc's Score
-0.11vs previous score
Forecast8.40
Financial Health7.15
Technical4.40
Valuation Dimensions7.44
Institutional Confidence5.00
Risk Assessment3.27
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Prelude Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Strong sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.14/-0.20
Revenue / Forecast
5.70M/0.00
Prelude Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolPRLD
Number of employees131
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| OrbiMed Advisors, LLC | 18.19% |
| Baker Bros. Advisors LP | 15.60% |
| RA Capital Management, LP | 9.98% |
| Incyte Corp | 6.73% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 24.56% |
| Private Equity | 18.19% |
| Venture Capital | 10.05% |
| Individual Investor | 7.10% |
Related Instruments
+1.26%
+0.79%
+0.20%
+0.55%
+0.16%
+0.04%
-0.30%
+0.08%
+2.41%
+0.21%
-0.74%
+1.78%
+2.39%
-0.19%
+0.52%
+0.45%
-3.45%
+1.47%
+1.06%
-2.17%
FAQs
What is the current price of Prelude Therapeutics Inc (PRLD)?
The current price of Prelude Therapeutics Inc (PRLD) is 3.45.
What is the symbol of Prelude Therapeutics Inc?
The ticker symbol of Prelude Therapeutics Inc is PRLD.
What is the 52-week high of Prelude Therapeutics Inc?
The 52-week high of Prelude Therapeutics Inc is 6.83.
What is the 52-week low of Prelude Therapeutics Inc?
The 52-week low of Prelude Therapeutics Inc is 1.29.
What is the market capitalization of Prelude Therapeutics Inc?
The market capitalization of Prelude Therapeutics Inc is 275.31M.
Is Prelude Therapeutics Inc (PRLD) currently rated as Buy, Hold, or Sell?
According to analysts, Prelude Therapeutics Inc (PRLD) has an overall rating of Buy, with a price target of 8.50.
What is the Earnings Per Share (EPS TTM) of Prelude Therapeutics Inc (PRLD)?
The Earnings Per Share (EPS TTM) of Prelude Therapeutics Inc (PRLD) is -1.00.